Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs

American Journal of Veterinary Research

Volumn 72, Issue 12, 2011, Pages 1576-1579

  Boscan, Pedro ^a   Monnet, Eric ^a   Mama, Khursheed ^a   Twedt, David C ^a   Congdon, Jonathan ^a   Steffey, Eugene P ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAROPITANT; SEVOFLURANE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL DOG; FEMALE; LAPAROSCOPY; MINIMUM LUNG ALVEOLUS CONCENTRATION; NOCICEPTIVE STIMULATION; NONHUMAN; OVARY FUNCTION; VISCERAL PAIN;

EID: 82755163953     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.12.1576     Document Type: Article

References (34)

1. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol Sci 2000;21:244-246.
2. Rost K, Fleischer F, Nieber K. Neurokinin 1 receptor antagonists- between hope and disappointment. Med Monatsschr Pharm 2006;29:200-205.
3. Laird JM, Olivar T, Roza C, et al. Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience 2000;98:345-352.
4. Ruggieri MR, Filer-Maerten S, Hieble JP, et al. Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder. J Urol 2000;164:197-202.
5. Okano S, Ikeura Y, Inatomi N. Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits. J Pharmacol Exp Ther 2002;300:925-931.
6. Laird J. Gut feelings about tachykinin NK1 receptor antagonists (lett). Trends Pharmacol Sci 2001;22:169.
7. Greenwood-Van Meerveld B, Gibson MS, Johnson AC, et al. NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig. Pharmacol Biochem Behav 2003;74:1005-1013.
8. Sakurada T, Katsumata K, Yogo H, et al. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test. Pain 1995;60:175-180.
9. Laird JM, Roza C, De Felipe C, et al. Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice. Pain 2001;90:97-103.
10. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305.
11. Gilron I. Is gabapentin a "broad-spectrum" analgesic? Anesthesiology 2002;97:537-539.
12. Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57:451-462.
13. Mitra S. Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag 2008;4:123-130.
14. Cohen SP, Christo PJ, Moroz L. Pain management in trauma patients. Am J Phys Med Rehabil 2004;83:142-161.
15. Brain SD. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 1997;37:133-152.
16. Inoue M, Kobayashi M, Kozaki S, et al. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc Natl Acad Sci U S A 1998;95:10949-10953.
17. Duggan AW, Hendry IA, Morton CR, et al. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988;451:261-273.
18. Lawson SN, Crepps BA, Perl ER. Relationship of substance P to afferent characteristics of dorsal root ganglion neurones in guinea-pig. J Physiol 1997;505:177-191.
19. Zachariou V, Goldstein BD, Yeomans DC. Low but not high rate noxious radiant skin heating evokes a capsaicin-sensitive increase in spinal cord dorsal horn release of substance P. Brain Res 1997;752:143-150.
20. Morris R, Cheunsuang O, Stewart A, et al. Spinal dorsal horn neurone targets for nociceptive primary afferents: do single neurone morphological characteristics suggest how nociceptive information is processed at the spinal level. Brain Res Brain Res Rev 2004;46:173-190.
21. Leah J, Menetrey D, De Pommery J. Neuropeptides in long ascending spinal tract cells in the rat: evidence for parallel processing of ascending information. Neuroscience 1988;24:195-207.
22. Battaglia G, Rustioni A. Substance P innervation of the rat and cat thalamus. II. Cells of origin in the spinal cord. J Comp Neurol 1992;315:473-486.
23. Gamboa-Esteves FO, Kaye JC, McWilliam PN, et al. Immunohistochemical profiles of spinal lamina I neurones retrogradely labelled from the nucleus tractus solitarii in rat suggest excitatory projections. Neuroscience 2001;104:523-538.
24. Andoh T, Nagasawa T, Kuraishi Y. Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse. Brain Res Mol Brain Res 1996;35:329-332.
25. Yip J, Chahl LA. Localization of tachykinin receptors and Foslike immunoreactivity induced by substance P in guinea-pig brain. Clin Exp Pharmacol Physiol 2000;27:943-946.
26. Mantyh PW, Gates T, Mantyh CR, et al. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989;9:258-279.
27. Boscan P, Monnet E, Mama K, et al. A dog model to study ovary, ovarian ligament and visceral pain. Vet Anaesth Analg 2011;38:260-266.
28. Eger EI II, Eisenkraft JB, Weiskopf RB. MAC. In: The pharmacology of inhaled anesthetics. Chicago: Baxter Healthcare Corp, 2003;21-32.
29. Kelly WB, Howie MB, Romanelli VA, et al. A comparison of pentamorphone and fentanyl in balanced anaesthesia during general surgery. Can J Anaesth 1994;41:703-709.
30. Ko JC, Weil AB, Inoue T. Effects of carprofen and morphine on the minimum alveolar concentration of isoflurane in dogs. J Am Anim Hosp Assoc 2009;45:19-23.
31. Machado CE, Dyson DH, Grant MM. Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs. Vet Anaesth Analg 2006;33:70-77.
32. McEwan AI, Smith C, Dyar O, et al. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 1993;78:864-869.
33. Murphy MR, Hug CC Jr. The enflurane sparing effect of morphine, butorphanol, and nalbuphine. Anesthesiology 1982;57:489-492.
34. Valverde A, Morey TE, Hernandez J, et al. Validation of several types of noxious stimuli for use in determining the minimum alveolar concentration for inhalation anesthetics in dogs and rabbits. Am J Vet Res 2003;64:957-962.